| Gene symbol | CCR5 | Synonyms | CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22 | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3p21.31 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | C-C motif chemokine receptor 5 | ||||
| GTO ID | GTC0318 |
| Trial ID | NCT02797470 |
| Disease | HIV Infection |
| Altered gene | CCR5 |
| Therapeutic/Target gene | Target gene |
| Therapy | shRNA |
| Treatment | CCR5 shRNA/TRIM5alpha/TAR decoy LV CD34+ cells |
| Co-treatment | Carmustine|Cytarabine|Etoposide|Melphalan |
| Phase | Phase1|Phase2 |
| Recruitment status | Active, Not Recruiting |
| Title | A Phase I Study of Stem Cell Gene Therapy for HIV Mediated by Lentivector Transduced, Pre-Selected CD34+ Cells |
| Year | 2016 |
| Country | United States |
| Company sponsor | AIDS Malignancy Consortium |
| Other ID(s) | AMC-097|NCI-2015-01745|9933|AMC 097|097|AMC-097|U01CA121947 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||
|
|||||||||||